
Danish industry association Dansk Biotek is ecstatic following the news that another Danish-Swedish venture fund focused on biotech has seen the light of day.
"This is really great news on several levels, and I am very excited. We can only be happy to have another competent player on the market," says Hans Schambye, chairman of industry association Dansk Biotek and CEO of Galecto Biotech, to MedWatch.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app